Drug recall · May 8, 2024
EYLEA, (aflibercept) Injection recall
Why: Lack of Assurance of Sterility: Complaints of syringe breakage
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
EYLEA, (aflibercept) Injection, 2 mg (0.05mL of a 40mg/mL solution), Single-dose Pre-filled Syringe, Rx only, Manufactured by: Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, NDC 61755-005-01
- Lots / codes
Lot # 8231500321, Exp 10/31 24; 8231500335, 8231500333, 8231500334, 8231500339, 8231500347, Exp 1/30/25
- Quantity
- 251,504 syringes
- Company
- Regeneron Pharmaceuticals Inc, Tarrytown, NY
- Distribution
- USA Nationwide
- Initiated
- April 23, 2024 · Voluntary: Firm initiated
- Classified
- May 2, 2024
- Reported
- May 8, 2024
- Ended
- September 25, 2025
- How notified
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.